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Retroviruses have evolved mechanisms for transporting their intron-containing RNAs
(including genomic and messenger RNAs, which encode virion components) from the
nucleus to the cytoplasm of the infected cell. Human retroviruses, such as human immun-
odeﬁciency virus (HIV) and human T cell leukemia virus type 1 (HTLV-1), encode the
regulatory proteins Rev and Rex, which form a bridge between the viral RNA and the
export receptor CRM1. Recent studies show that these transport systems are not only
involved in RNA export, but also in the encapsidation of genomic RNA; furthermore, they
inﬂuence subsequent events in the cytoplasm, including the translation of the cognate
mRNA, transport of Gag proteins to the plasma membrane, and the formation of virus
particles. Moreover, the mode of interaction between the viral and cellular RNA trans-
port machinery underlies the species-speciﬁc propagation of HIV-1 and HTLV-1, forming
the basis for constructing animal models of infection. This review article discusses recent
progress regarding these issues.
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Almost all eukaryote cellular messenger RNAs (mRNAs) undergo
splicing to remove introns, and only fully spliced mRNAs are able
to reach the cytoplasm (Legrain and Rosbash, 1989; Fischer et al.,
1994). The nuclear retention of unspliced, or incompletely spliced,
mRNAs is strictly regulated because incompletely spliced mRNAs
yield proteins that are non-functional, or even deleterious to the
cell. However, the expression of retroviral genes is a notable excep-
tion. Retroviruses are subdivided into two categories, simple and
complex, according to their genome structure (Goff, 2001). Sim-
ple retroviruses encode mainly structural genes, whereas complex
retroviruses harbor several accessory genes that play important
roles in their replication and pathogenesis. All retroviruses share
a common genome structure comprising long terminal repeat
(LTR) sequences at either end and centrally located gag, pol, and
env genes, which encode the component proteins of the viri-
ons (Figure 1). All except foamy viruses (Yu et al., 1996) utilize
the 5′-LTR as the sole promoter, resulting in the synthesis of a
single full-length viral RNA as the primary transcript. Since trans-
lation preferentially starts at the ﬁrst AUG codon (methionine)
in eukaryotes (Kozak, 1992), viruses must position the initiation
codons for all their genes (which are located within the primary
transcript) close enough to the 5′-cap to ensure appropriate and
efﬁcient translation. Retroviruses utilize alternative splicing of the
full-length transcript to produce the appropriate mRNAs. This
means that the introns of the full-length primary transcript encode
the gag gene, for instance. The mRNA must then be exported
and translated in the cytoplasm. In addition, viral genomic RNAs
(gRNAs), which are apparently indistinguishable to gag mRNA,
must be exported to the cytoplasm for viral replication. There-
fore, retroviruses have evolved the means to circumvent cellular
restrictions on the export of their intron-containingRNAs. Studies
regarding this issue have not only shed light on the mechanisms
underlying viral replication, but have also led to the discovery
of the nucleocytoplasmic transport systems in higher eukaryotes.
Moreover, recent ﬁndings indicate that the correct mode of nucle-
ocytoplasmic transport of viral RNA and proteins forms the basis
of subsequent cytoplasmic events involved in efﬁcient viral repli-
cation and, in some cases, forms the basis for species-speciﬁc
propagation.
TRANSPORT OF HTLV-1 RNA
Human T cell leukemia virus type 1 (HTLV-1) is the causative
agent of human adult T cell leukemia (ATL), a chronic progres-
sive neurological disorder termed HTLV-1-associated myelopa-
thy/tropical spastic paraparesis (HAM/TSP; Hinuma et al., 1981;
Kalyanaraman et al., 1982; Osame et al., 1986; Jacobson et al.,
1988), and other diseases. HTLV-1 encodes an unspliced, intron-
containing 9 kb RNA, which encodes Gag and Gag–Pol, a singly
spliced 4 kb mRNA encoding Env, and multiply spliced, intron-
free 2 kb mRNAs encoding Tax and Rex (Green and Chen, 2001).
Recently, the HTLV-1 leucine zipper factor (HBZ) gene was iden-
tiﬁed, which is encoded by a complimentary strand of the HTLV-1
genome, driven by a promoter residing in the 3′ LTR (Figure 1).
Tax and HBZ are implicated in oncogenesis (Satou et al., 2006;
Matsuoka and Jeang, 2011). Historically, Rex was the ﬁrst protein
to be identiﬁed as a factor that induces the cytoplasmic expres-
sion of intron-containing 9 and 4 kb RNAs (Inoue et al., 1986;
Hidaka et al., 1988). Rex binds directly to viral RNAs containing
Rex response element (RXRE) located in the 3′ LTR. RXRE, which
consists of a highly ordered stem-and-loop structure, functions as
a Rex binding site (Ballaun et al., 1991; Bogerd et al., 1991). Since
all HTLV-1 RNAs contain RXRE, Rex also enhances transport of
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FIGURE 1 | Structure of retrovirus genomes and RNAs
synthesized.The genome structure of simple retrovirus exempliﬁed
by MPMV and complex retroviruses including HTLV-1 and HIV-1 are
illustrated. Splicing patterns of viral mRNAs are also shown. Note
complex retroviruses, but not a simple retrovirus, synthesize doubly
spliced mRNAs.
fully spliced 2 kbmRNA,although this RNA can be transported via
the normal route for cellular mRNAs that do not require Rex (Bai
et al., 2012). The sequence elements that retain HTLV-1 unspliced
RNAs in the nucleus have been identiﬁed in the pol–env and LTR
regions of theHTLV-1 genome (Saiga et al., 1997;King et al., 1998).
An important property of Rex,which is essential for its role, is its
ability to dynamically shuttle between the cytoplasm and nucleus,
although Rex is predominantly localized in the nucleus and nucle-
olus (Bogerd et al., 1996; Kim et al., 1996; Siomi et al., 1988). Rex is
synthesized in the cytoplasm and then imported into the nucleus.
In the nucleus, Rex directly binds to RXRE, after which it escorts
the viral RNAs into the cytoplasm (Bogerd et al., 1991). Finally,Rex
is released from its cognate RNAs for recycling. Extensive muta-
tional analyses show that Rex contains functional domains that
are essential for its function (Figure 2). The basic domain is rich
in arginine residues and maps between amino acids (aa) 1–19 in
the 189 aa Rex protein. This domain serves as a nuclear/nucleolar
localization signal (NLS), and foreign proteins containing these
residues are localized to the nucleus/nucleolus (Siomi et al., 1988).
Importantly, the same region mediates binding to RXRE, thereby
determining its speciﬁc target RNA (Bogerd et al., 1991). The sec-
ond essential domain, which maps between aa 84 and 94 of Rex, is
a leucine-rich activation domain that functions as a nuclear export
signal (NES; Bogerd et al., 1996). The third important property of
Rex is multimerization. The domain responsible for this was ﬁrst
ascribed to a 60–70 aa region of Rex (Weichselbraun et al., 1992);
however, subsequent in vivo two-hybrid assays revealed that a 100–
120 aa region was also involved in multimerization (Heger et al.,
1998). Multimerization of Rex on its cognate RNA is generally
thought to be critical for its ability to export viral RNAs, although
it is not required for export of the Rex protein itself (Heger et al.,
1998). Although shuttling proteins have now been identiﬁed in a
wide range of other viral and cellular proteins, multimerization
may distinguish Rex from other shuttling proteins that are not
involved in RNA export since their multimerization is not neces-
sarily required for their functioning (Weichselbraun et al., 1992;
Bogerd and Greene, 1993; Heger et al., 1998).
A detailed understanding of Rex shuttling was obtained from
studies that identiﬁed the cellular factors binding to the functional
domains, and the cellular machinery involved in protein transport
into and out of the nucleus (Figure 3). Transport of all macromol-
ecules occurs via nuclear pore complexes (NPCs), which comprise
at least 50 different proteins, termednucleoporins (Doye andHurt,
1997). The import of proteins containing an NLS is mediated by
the importin family of import receptors, which have afﬁnity for
nucleoporins, and the GTP-bound status of Ran (RanGTP; Mattaj
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FIGURE 2 | Domain structures of HTLV-1 Rex and HIV-1 Rev proteins.
Note both proteins functionally similar domains and use the same cellular
cofactors.
FIGURE 3 | Schematic presentation of transport of HTLV-1 and HIV-1
RNAs. Action mechanism of viral transporter Rex/Rev and involvement of
their cellular cofactors are illustrated.
and Englmeier, 1998). Rex directly binds to importin β through
its NLS (Palmeri and Malim, 1999). Translocation through the
pore is thought to be facilitated by sequential direct interactions
between importin β and various nucleoporins. Ran is a small
GTPase that can exist in either the GTP or GDP-bound state.
RanGTP reﬂects the nuclear localization of chromatin binding
protein, RCC1, which speciﬁcally catalyzes the exchange of gua-
nine nucleotides on Ran, and RanGDP, the predominant form
of Ran in the cytoplasm, reﬂects the cytoplasmic location of a
GTPase-activating protein, RanGAP. One role of RanGTP is to
promote cargo release in the nucleus by dissociating the imported
receptor–cargo complexes; RanGDP has no afﬁnity for importin β
(Mattaj and Englmeier, 1998). Since the NLS of Rex overlaps with
its RNA binding domains, binding to importin β in the cytoplasm
may facilitate the release of viral RNAs from Rex (Bogerd et al.,
1991; Siomi et al., 1988; Palmeri and Malim, 1999).
The cellular cofactor that interacts with the NES of Rex is
human (h)CRM1. CRM1 was originally identiﬁed as binding the
NES of the human immunodeﬁciency virus (HIV)-1 Rev protein.
Sequence similarity to importin β suggested that hCRM1 was an
export receptor (Fornerod et al., 1997a; Fukuda et al., 1997). Subse-
quently, hCRM1 was shown to form a speciﬁc complex with NES;
however, unlike the Rex-importin β complex, this only occurred in
the presence of RanGTP (Fornerod et al., 1997a). The association
betweenRex andhCRM1was conﬁrmed in vivo using a two-hybrid
assay (Hakata et al., 1998). Moreover, CRM1 directly binds to
Ran-binding protein 3 (RanBP3), which binds to RCC1 in a Ran-
dependent manner and increases the nucleotide exchange activity
of RCC1, resulting in high local concentrations of RanGTP.Conse-
quently, RanBP3 acts as a scaffold protein through which the com-
ponents of the export complex are concentrated around the RCC1
site, thereby promoting complex assembly. RanBP3 continues to
interact with hCRM1 to stabilize the hCRM1–substrate–RanGTP
complex, thereby forming a quaternary complex (Englmeier et al.,
2001; Nemergut et al., 2002). Since CRM1 associates with various
nucleoporins (Fornerod et al., 1997b), theRex–hCRM1–RanGTP–
RanBP3 complex is translocated to the cytoplasm across the NPC;
this occurs via possible hydrophobic interactions between hCRM1
and nucleoporins. Following this, the RanGTP within the complex
is converted to RanGDP by RanGAP and RanBP1 (and probably
RanBP2), leading to the dissociation of the complex and release of
the substrate into the cytoplasm (Askjaer et al., 1999; Kehlenbach
et al., 1999).
An important question is whether cellular cofactors, such as
hCRM1, are involved in the multimerization of Rex proteins
(Hakata et al., 1998). Therefore, we examined the multimeriza-
tion of Rex proteins using a two-hybrid assay. First, we found
that a Rex mutant, RexM90 (which harbors a mutation in the
NES), lost the ability to bind to hCRM1 and to form multimers.
Second, we found that the RNA transport activity of RexM64,
which harbors a mutation in the multimerization domain, was
partially restored by the overexpression of hCRM1, and this coin-
cided with the partial restoration of multimerization. Third, a
dominant-negative (DN) mutant of Rex, termed TAgRexM64,
which sequesters Rex cofactors (Katahira et al., 1995), abrogated
the multimerization and activity of the wild-type Rex protein.
Both functions were simultaneously restored by the overexpres-
sion of hCRM1. Taken together, these results suggest that the
multimerization of Rex in vivo requires both the intrinsic abil-
ity of Rex to form multimers, and the hCRM1 protein. Moreover,
these results also suggest that the multimerization of Rex is not
a prerequisite for interaction with hCRM1 but, rather, that Rex
initially interacts with hCRM1, leading to the multimerization of
Rex proteins in a step that is favored by its intrinsic capacity to
form oligomers on RXRE. This, in turn, would favor a structure
that facilitates interactions with other hCRM1 molecules on the
RNA (Hakata et al., 1998). Comparison of human and rat CRM1
(rCRM1) mapped the CRM1 domain that induces Rex multimer-
ization to the central region, particularly a region containing two
residues (aa 411 and 414; Hakata et al., 2003); this domain is
different from the region spanning aa 566–720 that is involved in
binding to theNES (Ossareh-Nazari andDargemont, 1999). These
data suggest that CRM1 not only functions as an export receptor
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but also participates in the formation of the RNA export complex
through a high-order interaction with Rex. Curiously, the CRM1
region responsible for the interaction with RanBP3, which com-
prises four residues (aa 411, 414, 478, and 484), and the region
responsible for Rex multimerization form an overlapping domain
(Hakata et al., 2003).
RNA EXPORT STEP AS A MAJOR SPECIES-SPECIFIC
BARRIER FOR HTLV-1
Appropriate animal models of HTLV-1 infection would allow us to
analyze the pathogenesis and oncogenesis of HTLV-1-associated
diseases, which could lead to the development of therapeutic and
preventative measures. HTLV-1 is able to infect experimental ani-
mals such as monkeys, rabbits, and rats (Akagi et al., 1985; Naka-
mura et al.,1987;Oka et al.,1992). Theutility of monkey and rabbit
models is limited, however, because of the difﬁculties in breeding
a large number of these animals and the lack of inbred strains.
Consequently, it would be more convenient to use small animal
models. In particular, rat models have been extensively developed
to study HTLV-1-associated diseases (Ishiguro et al., 1992; Ohashi
et al., 2000). However, although the current rat models have cer-
tainly allowed us to understandHTLV-1-associated diseases better,
they are still incomplete because of the poor replication of HTLV-1
in rats.
Human T cell leukemia virus type 1 can infect a number of
rat cell types, which indicates that rat cells possess the receptors
for viral attachment and penetration (Li et al., 1996; Sutton and
Littman, 1996). Thus, the blockade of viral propagation within
the rat cells must occur during subsequent steps. Identiﬁcation of
the blocking step and the responsible host factor(s) could lead to
the construction of transgenic rats that express the critical human
factor(s), which are highly susceptible to HTLV-1 infection.
The ﬁrst hint of a blocking step came in a report showing that
the viralmRNAs encodingGag andEnvproteins are producedonly
at low levels in rat cells despite the fact that the mRNA for Tax/Rex
protein is abundant (Koya et al., 1999). This observation led us to
hypothesize that Rex may function poorly in rat cells. Indeed, we
found that the activity of Rex in rat cells is quite low comparedwith
that in human cells. As the functions of Rex depend largely on the
CRM1 protein, we examined whether rCRM1 can act as a cofactor
for Rex activity as it does in human cells, although CRM1 is highly
conserved from yeast to mammalians, and hCRM1 can function
in yeast cells as an export receptor. Actually, only 24 out of 1027
amino acids are different between rat and human CRM1 (Hakata
et al., 2003). Also, we found that both rCRM1 and hCRM1 could
bind to and export the Rex protein to the cytoplasm with similar
efﬁciency. However, unlike hCRM1, rCRM1 could not efﬁciently
support Rex function because of its poor ability to induce the
Rex–Rex interaction required for RNA export into the cytoplasm
(Figure 4). These results underline the absolute requirement of
hCRM1 for Rex multimerization. It was also concluded that the
poor ability of rCRM1 to act as a cofactor for Rex is responsible for
the poor replication of HTLV-1 in rats (Hakata et al., 2001). This
notion was further supported by a study showing that a HTLV-1-
transformed rat CD4+ T cell line, which was a poor producer of
HTLV-1, efﬁciently synthesized functional Env and Gag proteins,
which were then fully processed, and produced infectious HTLV-1
FIGURE 4 | Schematic presentation of transport defect of HTLV-1 RNA
caused by rat CRM1. Rex proteins multimerize with help of human CRM1
on HTLV-1 RNA to form transport complex in human cells, and then export
it to the cytoplasm. In contrast Rex proteins can bind to rat CRM1, but not
multimerize. Consequently Rex is not able to export HTLV-1 RNA in rat cells.
progeny viruses at the level comparable to HTLV-1-transformed
human T cells when it was transduced with a retroviral vector
expressing hCRM1 at physiological levels (Zhang et al., 2006).
Transgenic (Tg) rats were constructed using an artiﬁcial bacter-
ial chromosome clone containing the entire regulatory and coding
regions of the CRM1 gene (Figure 5), since the expression of the
CRM1 gene is elaborately regulated by a protein kinase C pathway
during lymphocyte activation, initially in a post-transcriptional
and subsequently in a transcriptional manner. Consequently, Tg
rats expressed hCRM1 protein in a manner similar to that of
intrinsic rCRM1 in various organs. HTLV-1-infected T cell lines
derived from these Tg rats produced 100- to 10,000-fold more
HTLV-1 than T cells from wild-type rats, and the absolute levels of
HTLV-1 were similar to those produced by human T cells. We also
observed increased dissemination of HTLV-1 into the thymuses
of Tg rats after intraperitoneal inoculation, although the proviral
loads were low in both wild-type and Tg rats (Takayanagi et al.,
2007). Furthermore, rat regulatory T (Treg) cells were preferen-
tially transformed by HTLV-1 (Takayanagi et al., 2009), as is the
case for human Treg cells (Chen et al., 2006). Therefore, the Tg rat
model forms the basis for an improved animal model for HTLV-1
infection.
RNA TRANSPORT OF HIV
Human immunodeﬁciency virus-1 belongs to the subfamily of
complex retroviruses and, like HTLV-1, also encodes accessory
genes besides gag and env; however, HIV-1 shows more complex
patterns of mRNA expression. HIV-1 produces one unspliced 9 kb
RNA encoding Gag and Gag–Pol, ﬁve singly spliced 4 kb mRNAs
encoding Vif, Vpr, Vpu, and Env, and 16 multiply spliced 2 kb
mRNAs encoding Tat, Rev, and Nef (Figure 1; Freed and Mar-
tin, 2001). As is the case for HTLV-1 Rex, the 9- and 4-kb viral
RNAs of HIV-1 require the viral protein Rev for export (Cullen,
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FIGURE 5 | Restoration of HTLV-1 production inT cells
prepared from human CRM1 transgenic rats.The BAC clone
harboring entire human CRM1 genome was microinjected to eggs
of rat F344 strain to construct transgenic rats. T cells prepared
from normal and hCRM1 transgenic rats were transformed by
mixed culture with mitomycin-treated HTLV-1+ humanT cell MT2.
Then the amounts of p19 Gag protein in the culture medium were
quantiﬁed by ELISA.
1991). However, expression of 2 kb RNAs is not augmented by
Rev, since the Rev response element (RRE), an approximately 300
nucleotide region with a highly ordered stem-and-loop structure
that functions as a Rev binding site, is located in the env gene rather
than the 3′ LTR (Malim et al., 1990; Mann et al., 1994). Conse-
quently, during the early phase of infection when Rev expression
is low, proteins encoded by the 2-kb class of mRNAs are expressed.
During the late phase, when Rev is expressed in sufﬁcient quanti-
ties, the remaining viral proteins are produced (Kim et al., 1989),
including the virion constituents and infectivity enhancing and
virion-releasing factors, all of which work toward the efﬁcient
production and dissemination of progeny virus.
Rev is a functional homolog of Rex, although Rev and Rex do
not show any homology at the amino acid level. However, they
do have similar domain structures and function in a similar man-
ner (Figures 2 and 3), as exempliﬁed by the fact that Rex can
replace Rev (Ahmed et al., 1990). The basic domain rich in argi-
nine residues, which maps between aa 35 and 50 in the 116 aa Rev
protein, serves as an NLS, which recruits importin β and binds to
the RRE (Daly et al., 1989; Malim et al., 1991; Tiley et al., 1992;
Madore et al., 1994). Replacing the amino-terminal domain of
the Rex protein with the RNA binding domain of the Rev pro-
tein yields a chimeric protein that can speciﬁcally interact with the
RRE (Kubota et al., 1991).A leucine-rich activation domain,which
maps between aa 73 and 83, acts as an NES that associates with
CRM1 in the presence of RanGTP (Fisher et al., 1995; Wen et al.,
1995). In vivo randomization selection experiments identiﬁed the
consensus sequence, which contains relatively evenly spaced bulky
hydrophobic residues (often leucine) that are crucial forNES func-
tion (Bogerd et al., 1996; Kim et al., 1996). In vitro studies of the
multimerization of recombinant Rev proteins bound to the RRE-
containing RNA deﬁned two essential domains: one between aa
12 and 33 and one between aa 46 and 60 (Malim et al., 1991).
The C-terminal region of Rev is highly conserved between HIV-
1 strains and supports efﬁcient multimerization and subsequent
Rev function, probably by stabilizing its conformation. In contrast
to Rex, Rev is able to dimerize without CRM1 molecules in vitro,
although in vivo two-hybrid assays suggest that CRM1 improves
dimerization (Chaitanya and Belasco, 2001; Hakata et al., 2002;
Matthew et al., 2008). Early studies suggested that Rev binds ini-
tially as amonomer to a single high-afﬁnity Rev binding sitewithin
the RRE (Battiste et al., 1996), but recent studies on the tertiary
structure of Rev indicate that the dimerization of Rev induces con-
formational changes in the position of the arginine-rich domain to
facilitate RNA binding (Daugherty et al., 2010). RNA bound to the
RRE augments further Rev multimerization, recruiting up to eight
Rev molecules on the viral RNA, which subsequently recruit sev-
eral hCRM1 molecules (Mann et al., 1994; Chaitanya and Belasco,
2001). Thus, multimerization, RNA binding to Rev, and Rev–
CRM1 interactions are highly cooperative processes. The process
is further accelerated by the DEAD (D–E–A–D=Asp–Glu–Ala–
Asp) box helicase,DDX1,which is an RNA-dependentATPase that
binds directly to Rev. Knockdown of DDX1 greatly reduces Rev
function, supporting the important role of DDX1 (Fang et al.,
2004; Robertson-Anderson et al., 2011; Edgcomb et al., 2012).
After the transport complex is formed, which comprises HIV-1
RNA, Rev, CRM1, and other cellular components, it moves to the
nuclear pores, possibly via the actin ﬁlament network (Kimura
et al., 2000). Multiple CRM1 molecules, which have afﬁnity for
nucleoporins, may be required to pass through the nuclear pore
because the transport complex could be longer than the depth of
thenuclear pore; thus, the rear portionof the complex is still within
the nucleus when the front portion reaches the cytoplasm. CRM1
molecules associated with Rev within the front portion of the
ribonucleoprotein complex (in the cytoplasm) will dissociate due
to the lack of RanGTP (Fornerod et al., 1997a). Thus, additional
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CRM1 molecules may be required to associate with the rear part
of the RNA complex to enable passage of the whole RNA complex
out of the nucleus. Another DEAD box protein, DDX3, which is
located outside of the nuclear pore, associates with CRM1 directly
and facilitates the passage of the complex through the nuclear pore
and the release of RNA into the cytoplasm by inducing conforma-
tional changes in the ribonucleoprotein complex (Yedavalli et al.,
2004). Additionally, Rip (also named Rab), which indirectly binds
to Rev and has afﬁnity for nuclear pores, is thought to function in
releasing the viral RNA within the cytoplasm (Sanchez-Velar et al.,
2004; Yu et al., 2005).
Suboptimal viral RNA splicing is also important for the func-
tion of Rev. Both inefﬁcient branch point region and polypyrim-
idine tract are thought to be responsible for the low splicing
efﬁciency of the HIV-1 tat/rev intron, which comprises most of
the HIV-1 env-coding sequences (Staffa and Cochrane, 1994).
Two additional elements, an exon-splicing enhancer (ESE) and
an exon-splicing silencer (ESS), both of which modulate the over-
all efﬁciency of the 3′ tat–rev splice site, were identiﬁed within the
3′ terminal exon (Staffa and Cochrane, 1995). It has been pro-
posed that inefﬁcient splicing causes the retention of unspliced, or
partially spliced, mRNAs since incomplete spliceosome formation
at the splice sites inhibits export (Chang and Sharp, 1989).
Secondary sequence elements, which retain unspliced HIV-
1 RNAs within the nucleus, are termed cis-acting repressive
sequences (CRSs) or instability sequences (INSs; Cochrane et al.,
1991; Maldarelli et al., 1991; Schneider et al., 1997). When
appended in cis to heterologous reporter genes, these elements
inhibit their expression. In situ hybridization studies demon-
strated discrete localization of unspliced gag and env RNAs. In
contrast to fully spliced mRNA, which is dispersed throughout
both the nucleus and cytoplasm, the location of unspliced gag and
env RNAs does not coincide with splicing factor SC35-containing
nuclear speckles. Deletion of the intron sequence containing the
CRS resulted in a shift from discrete regional localization within
the nucleus to a diffuse localization throughout the cell. On the
other hand, mutations that affect splicing efﬁciency do not alter
the sequestration of unspliced RNAs (Seguin et al., 1998). Based
on these results, one may hypothesize that CRSs (in conjunction
with other elements that cause suboptimal splicing) cause signif-
icant amounts of full-length primary RNA, or partially spliced
RNA, to accumulate. This RNA is inaccessible to subsequent splic-
ing due to its localization in discrete regions within the nucleus.
This sequestration of intron-containing RNAs may be a prereq-
uisite for subsequent export by Rev. Indeed, addition of the RRE
to β-globin mRNA, which contains efﬁcient splice sites, does not
make it responsive to Rev unless the splice sites are replaced by
more inefﬁcient ones, or a CRS is introduced into the mRNA. The
ﬁnding that hnRNPA1 and a 50-kDa protein associate with the
CRS suggests a connection between the CRS and RNA splicing,
since hnRNPA1 controls the selection of splice sites (Najera et al.,
1999).
RNA EXPORT AS A SPECIES-SPECIFIC BARRIER FOR HIV-1
Current animal models of HIV-1 disease use non-human primates
(Veazey et al., 2005; Koff et al., 2006) or severe combined immun-
odeﬁciency (SCID) mice transplanted with human hemopoietic
stem cells and fetal tissues (Shultz et al., 2007; Watanabe et al.,
2007). These models have made signiﬁcant contributions to our
understanding of lentiviral pathogenesis and have assisted in the
development of several therapeutic strategies. However, they also
have signiﬁcant shortcomings, such as limited availability and
high cost (for non-human primates), they are permissive only
for related retroviruses, and they often show aberrant immune
responses. Therefore, new animal models are needed. Rodent
models susceptible to infection by human viruses would be
ideal, since the inbred strains are well characterized and can be
genetically manipulated.
Studies on rodent cell-speciﬁc defects in the HIV-1 life cycle
have facilitated the identiﬁcation and characterization of host cell
gene products that are essential for viral replication, and these may
provide amolecular basis for generating fully permissive small ani-
mal models. The major block to HIV-1 replication is at the level of
cell entry. It is thought that this hurdle may be overcome by intro-
ducing human CD4 and CCR5 into the animal cells, which would
serve as receptors for HIV-1. However, Tg mice and rats expressing
human CD4 and CCR5 do not appear to support HIV-1 replica-
tion (Browning et al., 1997; Keppler et al., 2002; Gofﬁnet et al.,
2007), suggesting the presence of additional blocks post-entry.
Studies of the viral transcription activator,Tat, indicate the exis-
tence of a profound block at the transcription stage in murine cells
(Bieniasz et al., 1998;Garber et al., 1998) and in rat T cells but, curi-
ously, not in rat macrophages or ﬁbroblasts (Okada et al., 2009).
Expression of the human CyclinT1 (hCycT1), a cellular cofactor
for Tat, inmouse and rat T cells restored viral transcriptional activ-
ity (Okada et al., 2009). A single amino acid difference between
human and mouse CyclinT1 (mCycT1), which has a tyrosine at
residue 261 in place of the cysteine in hCycT1, caused almost com-
plete loss of Tat cofactor activity (Bieniasz et al., 1998;Garber et al.,
1998).
In contrast to the deﬁnitive results obtained for Rex in rat cells,
the existence of a profound block in Rev function in rodent cells
remains controversial, although a reduced level of the HIV-1 9 kb
transcript has been reported (Bieniasz and Cullen, 2000; Keppler
et al., 2001). Some studies have reported impaired Rev activity
(Trono and Baltimore, 1990; Marques et al., 2003), whereas oth-
ers have ascribed the reduced transcript levels to over splicing
or the reduced stability of unspliced transcripts in murine cells
compared with human cells (Malim and Cullen, 1991); a prob-
lem corrected by the expression of the human p32 protein (Zheng
et al., 2003). However, Malim et al found that the Gag protein
is still efﬁciently synthesized in murine cells, indicating that Rev
is functional, although it is not transported to the plasma mem-
brane, resulting in defective virion formation.When Gag mRNA is
transported via a different route using the cellular transporter,Tap,
instead of the Rev–CRM1 system,Gag proteinwas synthesized and
transported to the surface membrane, leading to efﬁcient virus
production (Swanson et al., 2004). This indicates that the RNA
export step is a one of the species-speciﬁc barriers to HIV-1 prop-
agation, and that the mode of mRNA nucleocytoplasmic transport
affects subsequent processes occurring in the cytoplasm.
The situation in rat cells is somewhat different to that inmurine
cells. Even when HIV-1 genes are expressed from transfected
plasmids (which circumvents the block at the entry step), virus
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production in rat cells is still poor. However, it increases markedly
in rat macrophages and ﬁbroblasts expressing hCRM1 (but only
marginally in rat T cells), which is in sharp contrast to cells trans-
fected with hCycT1 (Okada et al., 2009). Further analyses revealed
that hCRM1 enhanced Gag mRNA export a couple of times at
most in rat ﬁbroblasts. The amount of Gag protein within the
cells increased two to three times, which paralleled the increase
in Gag mRNA in the cytoplasm, although the trafﬁcking of Gag
to the plasma membrane did not increase. However, the number
of viral particles shed into the culture medium increased 20- to
50-fold, accompanied by the increased processing of the p55Gag
precursor to fully matured Gag proteins. Even a protease-deﬁcient
viral construct that caused accumulation of the p55 Gag precur-
sor in the cytoplasm facilitated the release of viral-like particles
in the presence of hCRM1, suggesting increased budding at the
plasma membrane. The N-terminal half of hCRM1 was found to
be responsible for this as the rCRM1–Rev interaction was much
less efﬁcient. These facts suggest that incomplete formation of
transport complexes in the nucleus may affect the mechanisms
underlying particle formation (Figure 6; Nagai-Fukataki et al.,
2011). Indeed, the interaction betweenRev and theRRE is essential
for proper encapsidation of gRNA into virus particles (Blissenbach
et al., 2010; Cockrell et al., 2011). Moreover, HIV-1 Gag proteins
gain access to the nucleus because they haveNLSs (Bukrinsky et al.,
1993) and NESs that associate with CRM1 (Dupont et al., 1999).
Thus, it would be interesting to examine the role of intra-nuclear
Gag proteins in virus morphogenesis. More studies are required
to conclude since contradictory results that NLS defective mutant
Gag proteins still support viral-like particle formation has been
also reported (Grewe et al., 2012).
RNA EXPORT OF SIMPLE RETROVIRUSES
Although simple retroviruses, exempliﬁed by the Mason-Pﬁzer
monkey virus (MPMV), encode only the gag, pol, and env genes
FIGURE 6 | Schematic presentation of RNA transport and particle
formation defect of HIV-1 caused by rat CRM1. In rat cells HIV-1 genomic
RNA and unspliced mRNA are inefﬁciently transported to the cytoplasm.
Additionally budding process is also affected. Expression of human CRM1
corrects both defects, suggesting linking of RNA nucleocytoplasmic
transport to the subsequent cytoplasmic event.
located centrally between the two LTRs (Figure 1; Goff, 2001),
they also require the means to circumvent cellular restrictions,
since the gag coding region is located within the intron of the
pre-mRNA encoding the envelope proteins. To express the intron-
containing gag mRNA and gRNA, inefﬁcient splicing is necessary
(as in the case of HIV-1), which is demonstrated by the ﬁnding
that the modiﬁcation of their splice sites increases their efﬁciency,
resulting in the over splicing of retroviral RNAs, which renders
the virus replication incompetent (Katz and Skalka, 1990). How-
ever, inefﬁcient splicing is not sufﬁcient; a sequence known as
the constitutive transport element (CTE; ﬁrst identiﬁed in the
3′-untranslation region of MPMV by Bray et al., 1994) is also
required for efﬁcient export. Since none of the simple retro-
viruses encode accessory proteins such as Rex and Rev, CTE was
thought to recruit cellular proteins. Subsequently, a cellular pro-
tein called transporter associated with antigen processing (TAP)
was identiﬁed, which binds CTE directly, and TAP sequence sim-
ilarity to yeast Mex67 (which is involved in mRNA transport)
indicates that CTE accesses the cellular mRNA export pathway
(Grüter et al., 1998; Katahira et al., 1999). The fact that the
RNA export pathway involving CTE is independent from those
involving RRE/Rev or RXRE/Rex was illustrated by its sensitiv-
ity to inhibition by a DN mutant, TAgRexM64, which inhibits
Rev/Rex function by sequestering the cellular cofactor, CRM1
(Katahira et al., 1995; Kiyokawa et al., 1997). The ribonucle-
oprotein complex containing simple retroviral RNA must also
undergo a conformational change during export, which is medi-
ated by RNA helicase A (Tang et al., 1997). Release of viral
RNA into the cytoplasm is mediated by another RNA helicase,
Dbp5, which localizes outside the nuclear pores (LeBlanc et al.,
2007).
An intriguing question is: are gRNA and unspliced gag mRNA
exported via different pathways that determine whether they
are encapsidated or translated, respectively? Rous sarcoma virus
(RSV), a simple avian retrovirus, contains direct repeat (DR)
elements (Ogert et al., 1996) thatmediate the cytoplasmic accumu-
lation of unspliced viral RNA in amanner similar to that of MPMV
CTE, since DN TAP and Dbp5 mutants abrogate DR-dependent
RNAexpression (LeBlanc et al., 2007).On theother hand,RSVGag
is reported to gain access to the nucleus via its NLS,which interacts
with importin α/β, transportin SR, and importin 11 (Butterﬁeld-
Gerson et al., 2006; Gudleski et al., 2010), and is exported via its
NES, which is associated with CRM1 (Scheifele et al., 2002, 2005).
Gag binds to gRNA at the packaging element, ψ, and another
unidentiﬁed site (D’Souza and Summers, 2005), and then forms
multimers ongRNAto assemble viral core particles (Scheifele et al.,
2007). Thus, it is conceivable that Gag proteins drive the transport
of viral particles formed in the nucleus. This notion is supported
by the following observations: First, transient nuclear trafﬁcking
of Gag is required for efﬁcient gRNA encapsidation (Garbitt-Hirst
et al., 2009), suggesting that Gag may initially bind to gRNA in
the nucleus. Second, formation of Gag:gRNA prevents the asso-
ciation between Gag and importins, while the binding of Gag to
gRNA instead enhances its association with CRM1, consequently
promoting the export of the Gag–gRNA complex to the cyto-
plasm (Gudleski et al., 2010; Parent, 2011). These facts suggest the
intriguing possibility that gag mRNA is transported through the
www.frontiersin.org May 2012 | Volume 3 | Article 179 | 7
Shida Nucleocytoplasmic RNA transport of retroviruses
TAP pathway to be translated,whereas gRNA (which appears to be
indistinguishable from gagmRNA), is exported by theGag–CRM1
pathway for encapsidation.
Detailed analyses on mouse mammary tumor virus (MMTV)
and human endogenous retrovirus K (HERV-K) that had been
initially classiﬁed as simple retroviruses revealed doubly spliced
mRNAs as the case of complex retroviruses. Moreover, such
mRNAs have been found to encode Rev like proteins such as
Rem in MMTV (Indik et al., 2005; Mertz et al., 2005) and K-
Rev in HERV-K (Yang et al., 1999) that export their cognate viral
RNAs through CRM1 pathway. The results suggest that these
viruses belong to complex retrovirus family. The presence of
K-Rev in HERV-K that integrated in primate genome ≥30 mil-
lion years ago may evoke the possibility of evolutional relation
in the acquisition of Rev by exogenous lentiviruses (Yang et al.,
1999).
CONCLUSION
Studies onRNA transport of retroviruses originally stemmed from
molecular biological interest on unusual function of Rex and
Rev that break the cellular blockage against transport of intron-
containing RNA. A great deal of investigation not only elucidated
their own mechanisms but also led discovery of the cellular nucle-
ocytoplasmic transport system. Moreover, recent studies showed
that the mode of RNA export inﬂuences subsequent events in the
cytoplasm, consequently affecting whole process of viral produc-
tion including the translation of the cognate mRNA, transport of
Gag proteins to the plasma membrane, and the formation of virus
particles. Lastly, the discovery on the interaction between the viral
and cellular RNA transport machinery as a species-speciﬁc bar-
rier of HIV-1 and HTLV-1 forms the basis to construct convenient
animal models of infection, which should facilitate development
of more potent therapeutic and preventing means.
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